Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC (AGN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Sector news Pharmaceuticals - NEC
01/19 CANADIAN CANNABIS FIRM AURORA IN TAL : sources
01/19 En route to Davos, Macron makes Versailles the place to be
01/19 SHIRE PLC SHIRE PLC : Directorate Change
01/19 At AstraZeneca, fewer drug projects bring big productivity jump
01/18 European shares edge higher as cyclicals back in favour
01/18 ABLYNX : Largest Ablynx investor would consider improved Novo Nordisk bid
01/18 BTG : U.S. court invalidates Johnson & Johnson cancer drug patent, hitting UK's ..
01/17 TSX ends up as banks lead rally after rate hike
01/17 ASPEN PHARMACARE : Drugmaker GSK cuts back in Africa to hone emerging markets mo..
01/17 EXCLUSIVE : J&J attracts Chinese interest for diabetes business in potential $3-..
01/17 Allergan Pact Advances -- WSJ
01/17 CELGENE : Conducts Deal Talks With Juno -- WSJ
01/17 Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareh..
01/16 CELGENE : in Talks to Buy Juno Therapeutics -- Update
01/16 CELGENE : in Talks to Buy Juno Therapeutics
01/16 Judge Signals He Will Approve $290 Million Settlement Between Allergan Shareh..
01/16 Health-conscious Nestle sells U.S. candy to Ferrero for $2.8 billion
01/16 ORGANIGRAM : Canopy Growth to supply cannabis to Prince Edward Island
01/15 Drugmaker Dermapharm gears up for likely first German IPO of 2018
01/12 Drugmakers see a pricing blueprint in an $850,000 gene therapy
01/12 SPARK'S PRICE FOR LUXTURNA BLINDNESS : Icer
01/12 ASTRAZENECA : Receives FDA Approval for Breast Cancer Treatment
01/12 WPP Buys London-based Mash Strategy
01/12 TEVA PHARMACEUTICAL INDUSTRIES : Ohio Talks Settlement Of Opioid Lawsuits -- WSJ
01/11 JOHNSON & JOHNSON : Ohio Takes Steps Toward Resolution of Opioid Litigation
01/11 JOHNSON & JOHNSON : Ohio in Talks to Settle Opioid Suit, State Attorney General ..
01/11 Bayer raises higher than expected 1.8 billion euros from Covestro placement
01/11 BAYER : Reduces Direct Stake in Covestro to 14.2%
01/10 Bayer to sell Covestro shares worth about $1.8 billion
01/10 Bond sell-off hits European shares but boost banks
01/10 BAYER : Further Reduces Stake in Covestro
01/10 TEVA PHARM DIRECTORS CUT THEIR SALAR : board member
01/10 TEVA PHARMACEUTICAL INDUSTRIES : Pharm directors cut their salaries in half - bo..
01/10 Nestle frontrunner for Merck KGaA's consumer health business - Bloomberg
01/10 BAYER : J&J win reversal of $28 million verdict in Xarelto lawsuit
01/09 BOSTON SCIENTIFIC : Health Care Up On Earnings Optimism -- Health Care Roundup
01/09 GLAXOSMITHKLINE : GSK CEO says looking at Pfizer consumer business, but not a pr..
01/09 U.S. pharma executives expect deals to pick up after tax overhaul
01/09 Drug Firm Rejects $3.13 Billion Offer From Novo Nordisk -- WSJ
01/09 Drug Industry Isn't Giving Up on Alzheimer's
01/08 SHIRE : cuts 2020 revenue target, prepares for spin-off of ADHD drugs
01/08 Ablynx soars after rejects Novo Nordisk's $3.1 billion biotech bid
01/08 European shares hit highest since August 2015, Ablynx soars
01/08 Weak results weigh on FTSE 100, profit warning pummels Mothercare
01/08 SHIRE : Announces Reorganization; Sets $17 Billion-$18 Billion Revenue Target
01/08 $11 billion biotech binge fuels forecasts of 2018 M&A surge
01/08 AXOVANT SCIENCES : shares plunge after key dementia drug programme scrapped
01/08 SANOFI : and Regeneron boost investment in cancer drug cemiplimab
01/08 Belgium's Ablynx Rejects EUR2.6 Billion Bid From Novo Nordisk
01/08 ROCHE : Partners With GE to Develop Integrated Digital Diagnostics Platform
Financials ($)
Sales 2017 15 892 M
EBIT 2017 7 624 M
Net income 2017 -6 499 M
Debt 2017 24 894 M
Yield 2017 1,58%
P/E ratio 2017 -
P/E ratio 2018
EV / Sales 2017 5,36x
EV / Sales 2018 5,45x
Capitalization 60 307 M
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
ALLERGAN PLC8.03%60 307
JOHNSON & JOHNSON5.20%395 886
NOVARTIS0.61%227 592
PFIZER2.65%220 189
ROCHE HOLDING LTD.-5.40%211 135
MERCK AND COMPANY10.24%167 132
AMGEN8.11%137 400
NOVO NORDISK A/S2.24%112 650
SANOFI0.72%112 597
BAYER-0.50%105 172
ABBOTT LABORATORIES3.36%103 235
BRISTOL-MYERS SQUIBB COMPANY0.93%101 934
ELI LILLY AND COMPANY2.07%94 133
GLAXOSMITHKLINE2.32%93 277
ASTRAZENECA-2.74%88 702
CELGENE CORPORATION-2.24%80 818
TAKEDA PHARMACEUTICAL CO LTD-0.52%46 200
SHIRE-11.47%43 739
JIANGSU HENGRUI MEDICINE CO LTD5.54%32 734
CHUGAI PHARMACEUTICAL CO LTD1.91%29 727
ASTELLAS PHARMA INC-4.59%25 854